The Delaware Chancery Court Monday allowed Boehringer Ingelheim Pharmaceuticals Inc. to move ahead with discovery in its trade secrets fight against United Therapeutics Corp., but rejected the drugmaker's request for a rapid-fire forensic discovery schedule, finding Boehringer waited too long to justify that level of emergency relief.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Chancery Allows Discovery In Boehringer Trade Secrets Fight | 0 | 7.85 | 05-10-2026 |
| 2 | Del. Justices Back Dismissal Of Gemini's Bausch & Lomb Suit | 0 | 5.98 | 02-10-2026 |
| 3 | TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation | 0 | 8.67 | 27-04-2026 |
| 4 | No Fee Sanction, But Reprimand For Eversheds In Del. Case | 0 | 7.24 | 05-10-2026 |
| 5 | Skechers Seeks To End Appraisal Claims After Settlement | 0 | 7.4 | 02-10-2026 |
| 6 | AIG Insurers Cleared In Del. To Appeal $50M Clawback Ruling | 0 | 8.94 | 02-10-2026 |
| 7 | Novartis Beats Patent Listing Suit Over Entresto | 0 | 7.9 | 24-09-2026 |
| 8 | Vein Tech Maker Escapes Suit Over DOJ Kickback Probe | 0 | 9.63 | 23-09-2026 |
| 9 | Google MDL Coverage Suit Belongs In Calif., Del. Judge Rules | 0 | 8.94 | 23-09-2026 |
| 10 | Match Group Hit With Del. Suit Over Dating App Safety | 0 | 8.54 | 24-09-2026 |